Pluri Inc. Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss
Pluri Inc. (PLUR) reported Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss of $26.00 thousand for the 12-month period ending 2013-06-30, per its 10-K filed 2013-09-11.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2013-09-11
- Pluri Inc. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2013 was $26.00K, a 766.67% increase from fiscal 2012.
- Pluri Inc. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2012 was $3.00K.
| Period end | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|
| 2013-06-30 | $26.00K 10-K · filed 2013-09-11 |
| 2012-06-30 | $3.00K 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |